2012 Midyear Clinical Meeting
Click here to go to the previous page
Debates in Therapeutics 2012
Track:
Education Sessions (CE)
Program Code: 219-L01
Date: Monday, December 3, 2012
Time: 3:00 PM to 5:00 PM EST
Location:
Lagoon K, Level 2, South Convention Center
PRESENTER(S):
Click the plus sign to see more detailed information about each speaker.
James Groce, III,
PharmD, CACP, Professor,
Campbell University College of Pharmacy & Health Sciences
|
James B. Groce III, PharmD, is Professor, Department of Pharmacy Practice at Campbell University College of Pharmacy and Health Sciences. He also is Clinical Assistant Professor of Medicine at the University of North Carolina School of Medicine, and Clinical Pharmacy Specialist-Anticoagulation at the Moses H. Cone Memorial Hospital in Greensboro, North Carolina.
Throughout his career in pharmacy, Dr. Groce has been published and cited on important healthcare topics in numerous peer-reviewed medical and pharmacy journals as well as textbooks of pharmacy. He has served as principal investigator on a number of studies, including many that supported the concept of outpatient treatment of venous thromboembolism. His published research has also evaluated the pharmacoeconomics of using low molecular weight heparins for outpatient treatment of deep venous thrombosis (DVT) in a community hospital setting, various heparin weight-based dosing nomograms, and the utility of heparin level determinations and outcomes analysis.
Dr. Groces colleagues and the public have benefited from his unique expertise. He served upon the Technical Advisory Panel of The Joint Commission/National Quality Forum for creation of core measures for prevention and treatment of venous thromboembolism which culminated in National Hospital Quality Measures for venous thromboembolism October 1, 2009. All these activities have earned Dr. Groce national and global recognition for his contributions to this clinical area of interest and research.
|
Michael Kane,
PharmD, FCCP, Professor,
Albany College of Pharmacy and Health Sciences
|
Michael P. Kane, Pharm.D., FCCP, BCPS, BCACP is a tenured Professor of Pharmacy Practice, Albany College of Pharmacy and Health Sciences and Clinical Pharmacy Specialist, at The Endocrine Group, LLP in Albany, NY.
After receiving his Bachelor of Science degree in Pharmacy from Albany College of Pharmacy and completing an ASHP-accredited hospital pharmacy residency at Greenwich Hospital in Greenwich, CT he attended the Medical University of South Carolina in Charleston, SC where he received his Pharm.D. degree and completed a Pharmacy Residency in Adult Internal Medicine. In 1991 he was among the first group of pharmacists in the country to become a Board Certified Pharmacotherapy Specialist. Twenty years later, he was among the first group of pharmacists in the country to become a Board Certified Ambulatory Care Pharmacist. After several years of an inpatient tertiary-care Adult Internal Medicine practice, he began an ambulatory care practice in 1997 with a group of private-practice endocrinologists at The Endocrine Group in Albany, NY. Mike has established pharmacist-referral Osteoporosis and Insulin-dosing Clinics within the practice. Since 2004, the clinics have seen over 1600 patients.
Dr. Kane received Fellow designation by the American College of Clinical Pharmacy in 2003. A past recipient of ACPHS Teacher of the Year, Dr. Kane has self-funded a post-Pharm.D. Residency program for the past ten years.
|
Denise Rhoney,
PharmD, FCCP, Associate Professor and Chair,
University of North Carolina Eshelman School of Pharmacy
|
Denise H. Rhoney, PharmD, FCCM, FCCP is Associate Professor and Chair for the Division of Practice Advancement and Clinical Education at the University of North Carolina Eshelman School of Pharmacy. After receiving her doctor of pharmacy at the University of Kentucky College of Pharmacy, she completed one residency in general clinical pharmacy and another residency in critical care specialty at the Albert B. Chandler Medical Center at the University of Kentucky. She also completed a clinical research fellowship at the University of North Carolina at Chapel Hill/Glaxo. After completion of fellowship she spent 16 years at Wayne State University working with the Neurocritical Care Team at Detroit Receiving Hospital before coming to UNC. Dr Rhoney's research has focused mainly on traumatic brain injury and acute stroke. She has an expertise in cerebrospinal fluid pharmacokinetics of pharmacologic agents and therapeutic optimization of neurocritical care. She has published 9 book chapters, 5 book reviews, and more than 100 articles and abstracts in Pharmacotherpay, Neurology, Neurocritical Care, and other journals. A fellow of both the American College of Critical Care Medicine and American College of Clinical Pharmacy, Dr Rhoney belongs to many other professional organizations, including the Neurocritical Care Society, where she currently serves on the Board of Directors. Dr Rhoney is the recipient of numerous honors and awards including the Presidential Award of Teaching Excellence at Wayne State University.
|
Daniel Riche,
PharmD, BCPS, Assistant Professor,
University of Mississippi
|
Dr. Daniel M. Riche received his Doctor of Pharmacy degree from the University of Louisiana at Monroe in 2005. His postgraduate training includes a Specialty Residency in Family Medicine at St. Louis College of Pharmacy co-affiliated with Mercy Family Medicine. Dr. Riche is the Clinic Coordinator of the Cardiometabolic Clinic at the University of Mississippi Medical Center, concentrating in metabolic disease states and providing pharmacotherapy teaching for medical and pharmacy residents and students. Dr. Riche was a University of Mississippi Faculty Research Program Fellow in 2008, received the University of Mississippi Clinical Science Teaching Award in 2009, and received the University of Mississippi Innovations in Teaching award in 2011. In 2011, Dr. Riche was named the American College of Clinical Pharmacy New Clinical Practitioner of the Year. Dr. Riche is the co-editor of the 11th Edition of Clinical Drug Data. Dr. Riche is a Board Certified Pharmacotherapy Specialist (BCPS) and a Certified Diabetes Educator (CDE). Outside of work, he enjoys spending time with his family, routing for the LSU Tigers, and traveling.
|
Andrew Smith,
PharmD, Clinical Assistant Professor,
University of Missouri - Kansas City School of Pharmacy
|
Dr. Andrew J. Smith is a clinical assistant professor at the University of Missouri-Kansas City School of Pharmacy. He received his doctor of pharmacy degree from UMKC in 2000. He then completed post-graduate training at the VA medical center in Iowa City, IA in 2001. Dr. Smith is a board certified pharmacotherapy specialist with added qualifications in cardiology. Prior to UMKC, Dr. Smith worked as a clinical pharmacist at KU hospital for seven years specializing in cardiology. Dr. Smiths clinical practice site is with the cardiology service at Truman Medical Center at Hospital Hill where he rounds with the inpatient cardiology consult service. His current projects include incorporation of web-based technology into pharmacy education as well as identifying barriers to cardiac rehabilitation participation.
|
Matthew Strum,
PharmD, BCACP, Clinical Assistant Professor,
University of Mississippi School of Pharmacy
|
Matthew Strum, Pharm.D., BCACP, CDE is a Clinical Assistant Professor in the Department of Pharmacy Practice at the University of Mississippi School of Pharmacy. He also is a clinical pharmacist at Oxford Endocrinology Consultants.
Dr. Strum's academic responsibilities include Pharmacy Practice Skills Lab III/IV, non-prescription medications, and Problem Solving I-IV. Dr. Strum also precepts students on an Ambulatory Care Introductory Pharmacy Practice Experience rotation in the third professional year and on an Ambulatory Care Advanced Pharmacy Practice Experience rotation during the fourth professional year.
Dr. Strum received his Bachelor of Science in Pharmaceutical Sciences and Doctor of Pharmacy degrees from the University of Mississippi School of Pharmacy. He completed a pharmacy practice residency emphasizing ambulatory care at The Regional Medical Center at Memphis where he concentrated his work in diabetes management and anticoagulation. Dr. Strum is a Board Certified Ambulatory Care Pharmacist, has been a Certified Diabetes Educator for over 10 years, and formerly a Certified Anticoagulation Care Provider. His area of interest is in ambulatory care, specifically in diabetes management, dyslipidemia, and hypertension. Dr. Strum is actively involved in several local and national organizations including the Mississippi Pharmacists Association, Mississippi Society of Health-System Pharmacists, ASHP, ACCP, and AADE.
|
Christopher Wood,
PharmD, Associate Professor,
University of Tennessee College of Pharmacy
|
G. Christopher Wood, Pharm.D., FCCP, BCPS is currently an Associate Professor of Clinical Pharmacy at the University of Tennessee College of Pharmacy. He completed the Pharm.D. degree in 1996, a critical care/nutrition support residency in 1997, and a critical care fellowship in 1999 all at the University of Tennessee. He then joined the faculty of UT in 1999 and was promoted to Associate Professor with tenure in 2005.
Dr. Woods clinical practice is in critical care at the Level 1 trauma center in the Regional Medical Center at Memphis, where he is also the program director for the PGY2 critical care residency. Dr. Wood is a Board Certified Pharmacotherapy Specialist with Added Qualifications in Infectious Diseases. He was elected as a Fellow of ACCP in 2007 and will be inducted as a Fellow of SCCM in 2013.
Dr. Woods primary research interest has been in improving the diagnosis and treatment of hospital-acquired infections. Dr. Wood has received funding as a principal or co-investigator from ACCP, ASHP, SIDP, SCCM and the pharmaceutical industry. He has published over 35 peer-reviewed manuscripts and over 25 book chapters and other publications. Dr. Wood also recently served on the SIDP guideline task force for aerosolized antimicrobials and the ACCP/ASHP/SCCM panel on critical care pharmacy services.
|
PROGRAM CHAIR:
Click the plus sign to see more detailed information about each speaker.
Matthew Strum,
PharmD, BCACP, Clinical Assistant Professor,
University of Mississippi School of Pharmacy
|
Matthew Strum, Pharm.D., BCACP, CDE is a Clinical Assistant Professor in the Department of Pharmacy Practice at the University of Mississippi School of Pharmacy. He also is a clinical pharmacist at Oxford Endocrinology Consultants.
Dr. Strum's academic responsibilities include Pharmacy Practice Skills Lab III/IV, non-prescription medications, and Problem Solving I-IV. Dr. Strum also precepts students on an Ambulatory Care Introductory Pharmacy Practice Experience rotation in the third professional year and on an Ambulatory Care Advanced Pharmacy Practice Experience rotation during the fourth professional year.
Dr. Strum received his Bachelor of Science in Pharmaceutical Sciences and Doctor of Pharmacy degrees from the University of Mississippi School of Pharmacy. He completed a pharmacy practice residency emphasizing ambulatory care at The Regional Medical Center at Memphis where he concentrated his work in diabetes management and anticoagulation. Dr. Strum is a Board Certified Ambulatory Care Pharmacist, has been a Certified Diabetes Educator for over 10 years, and formerly a Certified Anticoagulation Care Provider. His area of interest is in ambulatory care, specifically in diabetes management, dyslipidemia, and hypertension. Dr. Strum is actively involved in several local and national organizations including the Mississippi Pharmacists Association, Mississippi Society of Health-System Pharmacists, ASHP, ACCP, and AADE.
|
Description
Phenytoin Prophylaxis in Traumatic Brain Injury, Chris Wood, PharmD
Levetiracetam Prophylaxis in Traumatic Brain Injury, Denise Rhoney, PharmD, FCCP
PTN vs Levetiracetam in Traumatic Brain Injury: Rebuttals, Chris Wood, PharmD; Denise Rhoney, PharmD, FCCP
aPTT vs Anti-Xa Monitoring for Unfractionated Heparin - Pro aPTT, Andrew Smith, PharmD
aPTT vs Anti-Xa Monitoring for Unfractionated Heparin - Pro Anti-Xa, James B. Groce, III, PharmD
aPTT vs Anti-Xa Monitoring for Unfractionated Heparin Rebuttals, Andrew Smith, PharmD; James B. Groce, III, PharmD
Vitamin D Weekly or Daily Meekly? (Pro - Vitamin D Daily), Daniel M. Riche, PharmD
Vitamin D Weekly or Daily Meekly? (Pro - Vitamin D Weekly), Michael Kane, PharmD, FCCP
Vitamin D Weekly or Daily Meekly: Rebuttals, Daniel M. Riche, PharmD, BCPS; Michael Kane, PharmD, FCCP
- Compare the pro and con sides of selected therapeutic issues.
- Discuss why therapeutic controversy may occur.
- Identify four therapeutic areas in which controversy may exist.
